This review comprehensively discusses the activation mechanisms of three major innate immune pathways in lung cancer-cGAS-STING, TLR, and RLR signaling-the tumor-mediated negative regulatory mechanisms that suppress them, and their impact on the tumor immune microenvironment. This evidence concerns the gene STING1 and lung carcinoma.